See every side of every news story
Published loading...Updated

McKesson Canada expands patient access to cutting-edge Radioligand Therapy in Ontario

Summary by CDR – Chain Drug Review
MISSISSAUGA, Ontario – McKesson Canada annoounced this week it has started treating patients with radioligand therapy (RLT) at its newest INVIVA infusion clinic in Toronto, the first time this groundbreaking treatment has been available to patients outside of a hospital setting in Ontario.  "By offering radioligand therapy at INVIVA, we are expanding access to this transformative treatment for patients across the province, while also reinforcing…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

CDR – Chain Drug Review broke the news in on Friday, March 28, 2025.
Sources are mostly out of (0)

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.